Cite
HARVARD Citation
Gidwani, K. et al. (2016). A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources. Clinical chemistry. pp. 1390-1400. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gidwani, K. et al. (2016). A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources. Clinical chemistry. pp. 1390-1400. [Online].